7 research outputs found
Surrogate-assisted multi-objective optimization of the dynamic response of a freight wagon fitted with three-piece bogies
Assessment of sleep-related disorders in children with sickle cell disease
Sleep-related disorders (SRDs) are common in sickle cell disease, however, identification may be time-consuming. Simultaneous survey of multiple SRDs utilizing a simplified instrument would facilitate screening. A simplified questionnaire investigating SRDs [sleep-disordered breathing (SDB), restless legs syndrome (RLS), insomnia, parasomnias, and daytime effects of disrupted sleep] was administered to 2-18-year-old children with sickle cell disease. One hundred participants completed this 5-7 minute survey without difficulties: 54 awoke unrefreshed, 41 had short-term insomnia, 30 had sleep-maintenance insomnia, 21 had chronic sleep-onset insomnia, 54 had chronic habitual snoring and 11 met the criteria for RLS. Sleep-maintenance insomnia was associated with increased body mass index (BMI) (p = 0.001), and chronic sleep-onset insomnia was associated with higher hemoglobin (Hb) levels (p = 0.04). Survey-reported symptoms of SRDs were significantly higher than that reported in the general pediatric population. A fast and simplified SRD survey is feasible and suggests a high prevalence of SRDs in children with sickle cell disease
A comprehensive review of Toxoplasma gondii biology and host-cell interaction: Challenges for a plant-based vaccine
Toxoplasmosisis a worldwide-distributed infection caused by Toxoplasma gondii, which causes a wide range of clinical syndromesin humans, mammals and birds. T. gondiiis considered a parasite of veterinary and medical importance, because it maycause abortion or congenital disease in its intermediate hosts. Despite theeconomic losses associated with T. gondiiinfection in farm animals and the socio-economic impact caused by this zoonoticdisease in the human population, there is no effective treatment available forhumans or animals able to eliminate the parasite from the host once the chronicinfection has been established. The only commercial vaccine is the S48 strainof attenuated tachyzoites for use in sheep. However, this vaccine causes sideeffects, has a short life time and induces a short-term immunity. So far, noacellular vaccine against toxoplasmosis has been commercialized. In fact, futurechallenges include the development of an effective vaccine to preventtoxoplasmosis. Most parasitologists and vaccinologists agree that futureefforts should be concentrated on developing multi-antigen vaccines and moreefficient delivery systems able to express heterologous proteins abundantly aswell as on searching for immunization schedules and adequate adjuvants toenhance the protective responses. To achieve this, platforms for the productionof acellular vaccines based on the use of plants can have an important role.Fil: Sander, Valeria Analía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús). Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús); ArgentinaFil: Ángel, Sergio Oscar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús). Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús); ArgentinaFil: Clemente, Marina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús). Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús); Argentin